Salisbury Foundation Trust

FOI_5617

Internal Reference Number: FOI_5617

Date Request Received: 17/03/2020 08:58:02

Date Request Replied To: 06/05/2020 13:34:11

This response was sent via: By Email

Request Summary: Ovarian Cancer request

Request Category: Private Individuals

 
Question Number 1:
How many patients have been diagnosed over the last 6 months with epithelial ovarian, fallopian tube or primary peritoneal cancer?
If none, do you refer ovarian cancer patients to another trust, if so which one?
 
Answer To Question 1:
13 newly diagnosed
 
Question Number 2:
Of the ovarian patients, how many have been tested for BRCA mutation?
If unknown please state unknown and move to Question 4
 
Answer To Question 2:
8
 
Question Number 3:
Of the ovarian patient BRCA mutation tests how many tested positive?
 
Answer To Question 3:
<5, some results still pending.
 
Question Number 4:
Of the ovarian patients diagnosed over the last 6 months, how many have been treated with the below:
Paclitaxel in combination with a platinum-based compound
Platinum-based therapy alone (cisplatin or carboplatin)
Bevacizumab in combination with paclitaxel and carboplatin
Olaparib
Niraparib
Rucaparib
Pegylated liposomal doxorubicin hydrochloride (PLDH) as monotherapy or in combination with a platinum-based compound
 
Answer To Question 4:
Our pharmacy system does not hold diagnosis's. We have provided the total number of drugs prescribed regardless of diagnosis.

Paclitaxel in combination with a platinum-based compound 9
Platinum-based therapy alone (cisplatin or carboplatin) 2
Bevacizumab in combination with paclitaxel and carboplatin 5
Olaparib 1
Niraparib 3
Rucaparib 0
Pegylated liposomal doxorubicin hydrochloride (PLDH) as monotherapy or in combination with a platinum-based compound 1
 
Question Number 5:
Of those who were positive for a BRCA mutation, how many received Olaparib for 1st line maintenance?
 
Answer To Question 5:
<5
 
Question Number 6:
Of those who were positive for a BRCA mutation, how many received Bevacizumab in combination with paclitaxel and carboplatin for 1st line maintenance?
 
Answer To Question 6:
0
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2021 Salisbury NHS Foundation Trust
Trust Values